ZEISS expands Micro-CT research pipeline with the Beckman Institute for Advanced Science and Technology

The Beckman Institute accelerates research programs with revolutionary ZEISS Xradia 630 Versa Micro-CT scanner, the first 630 model for life science applications in the U.S.

WHITE PLAINS, N.Y., Aug. 13, 2024 /PRNewswire/ — Interdisciplinary researchers in Illinois, the U.S., and around the world are advancing their research projects with the Beckman Institute for Advanced Science and Technology‘s new ZEISS Xradia 630 Versa micro-CT scanner, the first of its kind with life science applications in the U.S.

Computed tomography, or CT, is an imaging technique that involves capturing a series of cross-sectional X-ray scans of an object or sample — be it a material like concrete or a biological sample like an insect or human body. Stacked on top of one another, the images non-invasively reconstruct the subject in 3D from the inside out. Microscopic, computed tomography, or micro-CT, helps researchers reconstruct subjects as tiny and delicate as collagen or insect antennae.

Most micro-CT scanners use only X-rays, which are invisible to the human eye, but Beckman’s new model also incorporates visible through a process called scintillation. The 630 Versa can also scan small subsections of large materials while maintaining a maximum imaging resolution of 40 nanometers, 2,500 times narrower than the width of a human hair.

“With building materials, hairline cracks are the start of where things go catastrophically wrong, and the micro-CT scanner at the Beckman Institute can see those cracks,” said Beckman microscopist T. Josek. “We’re providing the opportunity for researchers at the University of Illinois and beyond to start here and start small — see how a material behaves and what it looks like, and then scale up.”

Researchers can use the compression/tensile stage to stretch, bend, and compress their samples while scrutinizing them up close — a technique called in situ mechanical testing. The Versa 630 can also do diffraction contrast tomography, a technique wherein researchers can determine a material’s grain orientation by tracking how X-rays bend as they pass through it.

The scanner was installed in January 2024 and is the first 630 model for life science applications in the U.S. In addition to the Beckman Institute, the Illinois Materials Research Laboratory, The Grainger College of Engineering and the Office for the Vice Chancellor of Research and Innovation committed funds to support its purchase.

In partnership with Carl Zeiss Microscopy, the Beckman Microscopy Suite team is focused on finding projects on campus and beyond that might benefit from the Versa 630 and is providing comprehensive training for new users. 

“We at ZEISS are thrilled to be partnering with the Beckman Institute Microscopy Suite to deliver this flexible and intuitive system for X-ray microscopy,” said Aubrey Funke, Carl Zeiss Microscopy Product Marketing Manager for Life Science EM/XRM. “The ability to image your sample, be it organic or material, becomes a less intimidating process on the ZEISS Xradia Versa 630. With high powered-resolution and expanded ease-of-use for all skill levels, the Versa 630 is ideal for diverse research capabilities across various applications, including life science, electronics, materials research, and many more. We look forward to working with the Beckman Institute Microscopy Suite to support many diverse research projects. Researchers at the University of Illinois and beyond are encouraged to use the 630 Versa micro-CT scanner. For more information or to use the micro-CT scanner, please visit the Beckman Institute Microscopy Suite website at https://itg.beckman.illinois.edu/microscopy_suite.

The Beckman Institute for Advanced Science and Technology
The Beckman Institute for Advanced Science and Technology is an interdisciplinary research institute on the University of Illinois Urbana-Champaign campus. It is home to nearly 200 faculty members, 400 grad students, and 90 postdocs. Its researchers tackle topics like intelligence, molecules, and imaging. The result: scientific advances that couldn’t occur any other way. 

About ZEISS
ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 10 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2023).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With around 43,000 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 30 September 2023). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information at www.zeiss.com

ZEISS Research Microscopy Solutions
ZEISS Research Microscopy Solutions is the leading provider of light, electron, X-ray microscope systems, correlative microscopy and software solutions leveraging AI technologies. The portfolio comprises of products and services for life sciences, materials and industrial research, as well as education and clinical routine applications. The unit is headquartered in Jena. Additional production and development sites are located in Germany, UK, USA and China. ZEISS Research Microscopy Solutions is part of the Industrial Quality & Research segment. Further information at www.zeiss.com/microscopy

View original content to download multimedia:https://www.prnewswire.com/news-releases/zeiss-expands-micro-ct-research-pipeline-with-the-beckman-institute-for-advanced-science-and-technology-302220496.html

SOURCE ZEISS Research Microscopy Solutions

Staff

Recent Posts

Defence Announces Closing of Securities for Debenture Financing

Vancouver, British Columbia--(Newsfile Corp. - November 22, 2024) - DEFENCE THERAPEUTICS INC. (CSE: DTC) (OTCQB:…

4 minutes ago

NuGen Announces Canada-Wide Launch of InsuJet

3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across CanadaToronto, Ontario--(Newsfile Corp. - November 22,…

1 hour ago

purelyIV Launches Mobile App for Seamless Wellness Management

The new app allows users to browse services, book IV therapy, manage appointments, purchase packages,…

1 hour ago

Independence Blue Cross launches Epic Payer Platform to transform care coordination and boost member health outcomes

PHILADELPHIA, Nov. 22, 2024 /PRNewswire/ -- Independence Blue Cross (IBX) is implementing the Epic Payer Platform…

1 hour ago